0001121781-16-000576.txt : 20161118 0001121781-16-000576.hdr.sgml : 20161118 20161118160835 ACCESSION NUMBER: 0001121781-16-000576 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161114 FILED AS OF DATE: 20161118 DATE AS OF CHANGE: 20161118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUIDED THERAPEUTICS INC CENTRAL INDEX KEY: 0000924515 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 582029543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5835 PEACHTREE CORNERS EAST STREET 2: SUITE D CITY: NORCROSS STATE: GA ZIP: 30092 BUSINESS PHONE: 7702428723 MAIL ADDRESS: STREET 1: 5835 PEACHTREE CORNERS EAST STREET 2: SUITE D CITY: NORCROSS STATE: GA ZIP: 30092 FORMER COMPANY: FORMER CONFORMED NAME: SPECTRX INC DATE OF NAME CHANGE: 19970226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blumberg Richard P. CENTRAL INDEX KEY: 0001486345 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22179 FILM NUMBER: 162007895 MAIL ADDRESS: STREET 1: 2357 HOBART AVENUE S.W. CITY: SEATTLE STATE: WA ZIP: 98116 3 1 rblumbergfm3111716.xml OWNERSHIP DOCUMENT X0206 3 2016-11-14 0 0000924515 GUIDED THERAPEUTICS INC GTHP 0001486345 Blumberg Richard P. 5835 PEACHTREE CORNERS EAST SUITE D NORCROSS GA 30092 1 0 0 0 Common Stock 23 D Common Stock Warran (Right to Buy) 822.00 2014-12-02 2019-12-02 Common Stock 3 D Common Stock Warrant (Right to Buy) 822.00 2015-06-30 2020-06-29 Common Stock 3 D Common Stock Warrant (Right to Buy) 20400.00 2015-03-16 2020-03-15 Common Stock 3 D Common Stock Warrant (Right to Buy) 20400.00 2015-03-16 2020-03-15 Common Stock 5 D /S/ Gene Cartwright - Attorney In Fact 2016-11-14 EX-24 2 ex24.htm CONFIRMING STATEMENT

Exhibit 24

CONFIRMING STATEMENT

This Statement confirms that the undersigned, Richard P. Blumberg, has authorized and designated each of Gene Cartwright and Richard Fowler to execute and file on the undersigned’s behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of Guided Therapeutics, Inc. (the “Company”).

The authority of the aforementioned persons under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to his ownership of or transactions in securities of the Company, unless earlier revoked in writing. The undersigned acknowledges that neither of the aforementioned persons is assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

/s/ Richard P. Blumberg

Richard P. Blumberg

November 16, 2016